We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tenet Healthcare (THC) Falls More Steeply Than Broader Market: What Investors Need to Know
Read MoreHide Full Article
Tenet Healthcare (THC - Free Report) closed the latest trading day at $89.22, indicating a -1.12% change from the previous session's end. The stock's change was less than the S&P 500's daily loss of 0.17%. Meanwhile, the Dow experienced a drop of 0.06%, and the technology-dominated Nasdaq saw a decrease of 0.55%.
Heading into today, shares of the hospital operator had gained 9.05% over the past month, outpacing the Medical sector's gain of 5.93% and the S&P 500's gain of 3.98% in that time.
Investors will be eagerly watching for the performance of Tenet Healthcare in its upcoming earnings disclosure. It is anticipated that the company will report an EPS of $1.41, marking a 0.7% fall compared to the same quarter of the previous year. Simultaneously, our latest consensus estimate expects the revenue to be $5.12 billion, showing a 1.88% escalation compared to the year-ago quarter.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $5.92 per share and a revenue of $20.16 billion, representing changes of -15.19% and -1.89%, respectively, from the prior year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Tenet Healthcare. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the past month, there's been a 5.45% rise in the Zacks Consensus EPS estimate. Tenet Healthcare presently features a Zacks Rank of #3 (Hold).
Investors should also note Tenet Healthcare's current valuation metrics, including its Forward P/E ratio of 15.24. This expresses a discount compared to the average Forward P/E of 15.33 of its industry.
It is also worth noting that THC currently has a PEG ratio of 2.91. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Medical - Hospital industry had an average PEG ratio of 1.81 as trading concluded yesterday.
The Medical - Hospital industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 179, positioning it in the bottom 29% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Tenet Healthcare (THC) Falls More Steeply Than Broader Market: What Investors Need to Know
Tenet Healthcare (THC - Free Report) closed the latest trading day at $89.22, indicating a -1.12% change from the previous session's end. The stock's change was less than the S&P 500's daily loss of 0.17%. Meanwhile, the Dow experienced a drop of 0.06%, and the technology-dominated Nasdaq saw a decrease of 0.55%.
Heading into today, shares of the hospital operator had gained 9.05% over the past month, outpacing the Medical sector's gain of 5.93% and the S&P 500's gain of 3.98% in that time.
Investors will be eagerly watching for the performance of Tenet Healthcare in its upcoming earnings disclosure. It is anticipated that the company will report an EPS of $1.41, marking a 0.7% fall compared to the same quarter of the previous year. Simultaneously, our latest consensus estimate expects the revenue to be $5.12 billion, showing a 1.88% escalation compared to the year-ago quarter.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $5.92 per share and a revenue of $20.16 billion, representing changes of -15.19% and -1.89%, respectively, from the prior year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Tenet Healthcare. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the past month, there's been a 5.45% rise in the Zacks Consensus EPS estimate. Tenet Healthcare presently features a Zacks Rank of #3 (Hold).
Investors should also note Tenet Healthcare's current valuation metrics, including its Forward P/E ratio of 15.24. This expresses a discount compared to the average Forward P/E of 15.33 of its industry.
It is also worth noting that THC currently has a PEG ratio of 2.91. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Medical - Hospital industry had an average PEG ratio of 1.81 as trading concluded yesterday.
The Medical - Hospital industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 179, positioning it in the bottom 29% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.